Envelope-chimeric Entry-targeted Measles Virus Escapes Neutralization and Achieves Oncolysis

Measles virus (MV) is a promising vector for cancer therapy and multivalent vaccination, but high prevalence of pre-existing neutralizing antibodies may reduce therapeutic efficacy, particularly following systemic administration. MV has only one serotype, but here we show that its envelope glycoprot...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Miest, Tanner S, Yaiw, Koon-Chu, Frenzke, Marie, Lampe, Johanna, Hudacek, Andrew W, Springfeld, Christoph, von Messling, Veronika, Ungerechts, Guy, Cattaneo, Roberto
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2011
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188758/
https://ncbi.nlm.nih.gov/pubmed/21610701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.92
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg